Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal Elderly adults at 3-tesla.

QUASAR arterial spin labeling (ASL) was used to investigate the role of vascular impairment in Alzheimer's disease (AD). We hypothesized that the hemodynamic parameters monitoring cerebrovascular integrity, i.e., cerebral blood flow (CBF), arterial blood volume (aBV), and arterial transit time (aTT), would be affected. 13 AD patients and 15 healthy control (HC) subjects underwent 3T MRI scanning. Two separate blood flow acquisitions were obtained with 1 slice overlap for whole brain coverage. CBF, aBV, and aTT maps were calculated using in-house software. Preprocessing and statistical analyses were performed on SPM5. Region-of-interest (ROI) studies of ten selected cerebral regions were also conducted. There were significant differences in mini mental status exam (MMSE) (AD: 16.3 ± 4.55, HC: 28.5 ± 2.00) and Alzheimer's disease assessment scale-cognitive subscale (ADAS-cog) scores (AD: 25.25 ± 9.64, HC: 5.51 ± 2.62) between the 2 groups (p < 0.001) but none in age (p = 0.068). CBF decreased significantly (p < 0.01) in AD compared to controls in the right middle cingulate, left cuneus, left inferior and middle frontal, right superior frontal, left inferior parietal, and right supramarginal gyri. ROI studies confirmed significant hemodynamic impairments in AD compared to HC (p < 0.05): CBF in middle and posterior cingulate, aBV in left superior temporal, right inferior parietal, and posterior cingulate, and aTT in left inferior frontal and middle cingulate gyri. CBF correlated positively while aTT correlated negatively to MMSE, and vice versa for ADAS-cog. Using QUASAR ASL, we found patterns of regional hemodynamic impairment typical of moderate AD, suggesting underlying vascular abnormality. As potential biomarkers, these hemodynamic parameters could differentiate patients from volunteers, and possibly indicate the conversion from healthy aging to mild cognitive impairment to AD.

[1]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[2]  J. Detre,et al.  Assessment of cerebral blood flow in Alzheimer's disease by spin‐labeled magnetic resonance imaging , 2000, Annals of neurology.

[3]  Gregory G. Brown,et al.  Measurement of cerebral perfusion with arterial spin labeling: Part 1. Methods , 2007, Journal of the International Neuropsychological Society.

[4]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[5]  J. Detre,et al.  Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. , 2000, Stroke.

[6]  S. Francis,et al.  Noninvasive measurement of arterial cerebral blood volume using look‐locker EPI and arterial spin labeling , 2007, Magnetic resonance in medicine.

[7]  K. Yamashita,et al.  Simultaneous Measurement of Arterial Transit Time, Arterial Blood Volume, and Cerebral Blood Flow Using Arterial Spin-Labeling in Patients with Alzheimer Disease , 2009, American Journal of Neuroradiology.

[8]  J. C. Torre,et al.  Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer’s pathogenesis , 2000, Neurobiology of Aging.

[9]  H. Mak,et al.  Computed tomography evaluation of intracranial atherosclerosis in Chinese patients with transient ischemic attack or minor ischemic stroke--its distribution and association with vascular risk factors. , 2009, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[10]  Mark A. Smith,et al.  Vascular abnormalities: the insidious pathogenesis of Alzheimer’s disease☆ , 2000, Neurobiology of Aging.

[11]  R. Coleman,et al.  Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. , 2003, Radiology.

[12]  R. V. Van Heertum,et al.  SPECT perfusion imaging in the diagnosis of Alzheimer’s disease , 2001, Neurology.

[13]  F. Schmitt,et al.  Assessing Utility of Single Photon Emission Computed Tomography (SPECT) Scan in Alzheimer Disease: Correlation with Cognitive Severity , 1990, Alzheimer disease and associated disorders.

[14]  N. Foster,et al.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.

[15]  Linda Zhang,et al.  Efficacy of voxel-based morphometry with DARTEL and standard registration as imaging biomarkers in Alzheimer's disease patients and cognitively normal older adults at 3.0 Tesla MR imaging. , 2011, Journal of Alzheimer's disease : JAD.

[16]  James T Becker,et al.  Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. , 2009, Radiology.

[17]  X. Golay,et al.  Perfusion Imaging Using Arterial Spin Labeling , 2004, Topics in magnetic resonance imaging : TMRI.

[18]  N. Schuff,et al.  Patterns of Cerebral Hypoperfusion in Amnestic and Dysexecutive MCI , 2009, Alzheimer disease and associated disorders.

[19]  J. Hendrikse,et al.  Arterial Spin-Labeling MR Imaging Measurements of Timing Parameters in Patients with a Carotid Artery Occlusion , 2008, American Journal of Neuroradiology.

[20]  J. Petrella,et al.  Current status of functional MR imaging, perfusion-weighted imaging, and diffusion-tensor imaging in Alzheimer's disease diagnosis and research. , 2005, Neuroimaging clinics of North America.

[21]  Esben Thade Petersen,et al.  Model‐free arterial spin labeling quantification approach for perfusion MRI , 2006, Magnetic resonance in medicine.

[22]  W. Jagust.  Neuroimaging in dementia. , 2000, Neurologic clinics.

[23]  Yi-Ching Lynn Ho,et al.  Similarities and Differences in Arterial Responses to Hypercapnia and Visual Stimulation , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  Gregory G Brown,et al.  Measurement of cerebral perfusion with arterial spin labeling: Part 2. Applications , 2007, Journal of the International Neuropsychological Society.

[25]  I Zimine,et al.  Clinical Application of Arterial Spin-Labeling MR Imaging in Patients with Carotid Stenosis: Quantitative Comparative Study with Single-Photon Emission CT , 2011, American Journal of Neuroradiology.

[26]  Kim Mouridsen,et al.  The QUASAR reproducibility study, Part II: Results from a multi-center Arterial Spin Labeling test–retest study , 2010, NeuroImage.

[27]  J. C. Torre.  Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics , 2004, The Lancet Neurology.

[28]  D. Benson,et al.  The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. , 1983, Archives of neurology.

[29]  Frederik Barkhof,et al.  Pathological Aging of the Brain: An Overview , 2004, Topics in magnetic resonance imaging : TMRI.

[30]  R. Kalaria.  The role of cerebral ischemia in Alzheimer’s disease , 2000, Neurobiology of Aging.

[31]  D Comar,et al.  Differential diagnosis of Alzheimer's disease with PET. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  E. Shimosegawa,et al.  Hemodynamic Aspects of Alzheimer's Disease , 2002, Annals of the New York Academy of Sciences.

[33]  J. Detre,et al.  Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[34]  B J Shepstone,et al.  Accurate Prediction of Histologically Confirmed Alzheimer's Disease and the Differential Diagnosis of Dementia: The Use of NINCDS-ADRDA and DSM-III-R Criteria, SPECT, X-Ray CT, and Apo E4 in Medial Temporal Lobe Dementias , 1998, International Psychogeriatrics.

[35]  N. Schuff,et al.  Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. , 2005, Radiology.